Clinical Trial: ME-344 and Bevacizumab in Previously Treated Metastatic Colorectal Cancer
Study Status: Completed
Recruit Status: RECRUITING
Condition: Colorectal Cancer
Study Type: INTERVENTIONAL
Official Title: A Phase 1b Study of the OxPhos Inhibitor ME-344 Combined With Bevacizumab in Previously Treated Metastatic Colorectal Cancer
Brief Summary:
This is a Phase 1b open-label, multiple dose/schedule sequential study to determine the safety and efficacy of the oxidative phosphorylation (OxPhos) pathway inhibitor ME-344 in combination with bevacizumab in subjects with recurrent mCRC.
Read more